Maladaptive Dendritic Spine Remodeling Contributes to Diabetic Neuropathic Pain

Overview

Journal J Neurosci

Specialty Neurology

Date 2012 May 18

PMID 22593049

Citations 46

Authors

Andrew M Tan

Omar A Samad

Tanya Z Fischer

Peng Zhao

Anna-Karin Persson

Stephen G Waxman

Affiliations

Soon will be listed here.

Abstract

Diabetic neuropathic pain imposes a huge burden on individuals and society, and represents a major public health problem. Despite aggressive efforts, diabetic neuropathic pain is generally refractory to available clinical treatments. A structure-function link between maladaptive dendritic spine plasticity and pain has been demonstrated previously in CNS and PNS injury models of neuropathic pain. Here, we reasoned that if dendritic spine remodeling contributes to diabetic neuropathic pain, then (1) the presence of malformed spines should coincide with the development of pain, and (2) disrupting maladaptive spine structure should reduce chronic pain. To determine whether dendritic spine remodeling contributes to neuropathic pain in streptozotocin (STZ)-induced diabetic rats, we analyzed dendritic spine morphology and electrophysiological and behavioral signs of neuropathic pain. Our results show changes in dendritic spine shape, distribution, and shape on wide-dynamic-range (WDR) neurons within lamina IV-V of the dorsal horn in diabetes. These diabetes-induced changes were accompanied by WDR neuron hyperexcitability and decreased pain thresholds at 4 weeks. Treatment with NSC23766 (N(6)-[2-[[4-(diethylamino)-1-methylbutyl]amino]-6-methyl-4-pyrimidinyl]-2-methyl-4,6-quinolinediamine trihydrochloride), a Rac1-specific inhibitor known to interfere with spine plasticity, decreased the presence of malformed spines in diabetes, attenuated neuronal hyperresponsiveness to peripheral stimuli, reduced spontaneous firing activity from WDR neurons, and improved nociceptive mechanical pain thresholds. At 1 week after STZ injection, animals with hyperglycemia with no evidence of pain had few or no changes in spine morphology. These results demonstrate that diabetes-induced maladaptive dendritic spine remodeling has a mechanistic role in neuropathic pain. Molecular pathways that control spine morphogenesis and plasticity may be promising future targets for treatment.

Citing Articles

Understanding of Spinal Wide Dynamic Range Neurons and Their Modulation on Pathological Pain.

Zhang Z, Zheng H, Yu Q, Jing X J Pain Res. 2024; 17:441-457.

PMID: 38318328 PMC: 10840524. DOI: 10.2147/JPR.S446803.

Tiam1 coordinates synaptic structural and functional plasticity underpinning the pathophysiology of neuropathic pain.

Li L, Ru Q, Lu Y, Fang X, Chen G, Saifullah A Neuron. 2023; 111(13):2038-2050.e6.

PMID: 37146610 PMC: 10330505. DOI: 10.1016/j.neuron.2023.04.010.

Rac1/PAK1 signaling contributes to bone cancer pain by Regulation dendritic spine remodeling in rats.

Xu L, Yang L, Wu Y, Wan X, Tang X, Xu Y Mol Pain. 2023; 19:17448069231161031.

PMID: 36938611 PMC: 10028669. DOI: 10.1177/17448069231161031.

The mechanism of exercise for pain management in Parkinson's disease.

Yu W, Yang Q, Wang X Front Mol Neurosci. 2022; 15:1039302.

PMID: 36438185 PMC: 9684336. DOI: 10.3389/fnmol.2022.1039302.

Recent updates in the treatment of diabetic polyneuropathy.

Fan Q, Smith A Fac Rev. 2022; 11:30.

PMID: 36311537 PMC: 9586156. DOI: 10.12703/r/11-30.

References

Chang Y, Tan A, Saab C, Waxman S . Unilateral focal burn injury is followed by long-lasting bilateral allodynia and neuronal hyperexcitability in spinal cord dorsal horn. J Pain. 2009; 11(2):119-30. DOI: 10.1016/j.jpain.2009.06.009. View

Gjerstad J, Tjolsen A, Hole K . Induction of long-term potentiation of single wide dynamic range neurones in the dorsal horn is inhibited by descending pathways. Pain. 2001; 91(3):263-268. DOI: 10.1016/S0304-3959(00)00448-6. View

Morgado C, Pereira-Terra P, Cruz C, Tavares I . Minocycline completely reverses mechanical hyperalgesia in diabetic rats through microglia-induced changes in the expression of the potassium chloride co-transporter 2 (KCC2) at the spinal cord. Diabetes Obes Metab. 2011; 13(2):150-9. DOI: 10.1111/j.1463-1326.2010.01333.x. View

Nakayama A, Luo L . Intracellular signaling pathways that regulate dendritic spine morphogenesis. Hippocampus. 2000; 10(5):582-6. DOI: 10.1002/1098-1063(2000)10:5<582::AID-HIPO8>3.0.CO;2-K. View

Pertovaara A, Wei H, Kalmari J, Ruotsalainen M . Pain behavior and response properties of spinal dorsal horn neurons following experimental diabetic neuropathy in the rat: modulation by nitecapone, a COMT inhibitor with antioxidant properties. Exp Neurol. 2001; 167(2):425-34. DOI: 10.1006/exnr.2000.7574. View

Chaplan S, Bach F, Pogrel J, Chung J, Yaksh T . Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994; 53(1):55-63. DOI: 10.1016/0165-0270(94)90144-9. View

Ohsawa M, Aasato M, Hayashi S, Kamei J . RhoA/Rho kinase pathway contributes to the pathogenesis of thermal hyperalgesia in diabetic mice. Pain. 2010; 152(1):114-122. DOI: 10.1016/j.pain.2010.10.005. View

Ossipov M, Bian D, Malan Jr T, Lai J, Porreca F . Lack of involvement of capsaicin-sensitive primary afferents in nerve-ligation injury induced tactile allodynia in rats. Pain. 1999; 79(2-3):127-33. DOI: 10.1016/s0304-3959(98)00187-0. View

Chen L, Rex C, Babayan A, Kramar E, Lynch G, Gall C . Physiological activation of synaptic Rac>PAK (p-21 activated kinase) signaling is defective in a mouse model of fragile X syndrome. J Neurosci. 2010; 30(33):10977-84. PMC: 2929244. DOI: 10.1523/JNEUROSCI.1077-10.2010. View

10.

Fischer T, Waxman S . Neuropathic pain in diabetes--evidence for a central mechanism. Nat Rev Neurol. 2010; 6(8):462-6. DOI: 10.1038/nrneurol.2010.90. View

11.

Tan A, Stamboulian S, Chang Y, Zhao P, Hains A, Waxman S . Neuropathic pain memory is maintained by Rac1-regulated dendritic spine remodeling after spinal cord injury. J Neurosci. 2008; 28(49):13173-83. PMC: 6671613. DOI: 10.1523/JNEUROSCI.3142-08.2008. View

12.

Yamano T, Shimada M, Fujizeki Y, Kawasaki H, Onaga A . Quantitative synaptic changes on Purkinje cell dendritic spines of rats born from streptozotocin-induced diabetic mothers. Brain Dev. 1986; 8(3):269-73. DOI: 10.1016/s0387-7604(86)80080-8. View

13.

RALL W . Theory of physiological properties of dendrites. Ann N Y Acad Sci. 1962; 96:1071-92. DOI: 10.1111/j.1749-6632.1962.tb54120.x. View

14.

Tan A, Zhao P, Waxman S, Hains B . Early microglial inhibition preemptively mitigates chronic pain development after experimental spinal cord injury. J Rehabil Res Dev. 2009; 46(1):123-33. View

15.

Ahlgren S, Levine J . Protein kinase C inhibitors decrease hyperalgesia and C-fiber hyperexcitability in the streptozotocin-diabetic rat. J Neurophysiol. 1994; 72(2):684-92. DOI: 10.1152/jn.1994.72.2.684. View

16.

Tan A, Choi J, Waxman S, Hains B . Dendritic spine remodeling after spinal cord injury alters neuronal signal processing. J Neurophysiol. 2009; 102(4):2396-409. DOI: 10.1152/jn.00095.2009. View

17.

Gao Y, Dickerson J, Guo F, Zheng J, Zheng Y . Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc Natl Acad Sci U S A. 2004; 101(20):7618-23. PMC: 419655. DOI: 10.1073/pnas.0307512101. View

18.

Ohsawa M, Kamei J . RhoA/Rho kinase signaling in the spinal cord and diabetic painful neuropathy. Eur J Pharmacol. 2010; 644(1-3):1-4. DOI: 10.1016/j.ejphar.2010.07.007. View

19.

Pabreja K, Dua K, Sharma S, Padi S, Kulkarni S . Minocycline attenuates the development of diabetic neuropathic pain: possible anti-inflammatory and anti-oxidant mechanisms. Eur J Pharmacol. 2011; 661(1-3):15-21. DOI: 10.1016/j.ejphar.2011.04.014. View

20.

Bays H, Pfeifer M . Peripheral diabetic neuropathy. Med Clin North Am. 1988; 72(6):1439-64. DOI: 10.1016/s0025-7125(16)30716-7. View